Riaz Bandali

Riaz Amirali Bandali is currently an Independent Non-Executive Director at Instem Ltd. since 2021 and President at Nordion (Canada), Inc. Former positions include President & Chief Executive Officer at Emerald Health Therapeutics, Inc. from 2019 to 2021, Director at Genetronics Biomedical Corp., Director at Inovio Pharmaceuticals, Inc. in 2009, Non-Executive Director at Nuvelution Pharma, Inc. from 2019 to 2021, Director at Pure Sunfarms Corp., SVP-Strategy & Business Development at Molecular Devices LLC in 2010, President-Early Stage at inVentiv Health Clinical, Inc. in 2013, Vice President at Lumira Capital Investment Management, Inc. from 1994 to 2013, Vice President & GM-Global Early Clinical Research at MDS Pharma Services (Canada) from 2006 to 2008, Senior VP-Strategy, Legal & Corporate Development at MDS Analytical Technologies (US), Inc., SVP-Business Development & Operations at MDS Sciex, Chief Financial Officer & SVP-Business Development at Apoptogen, Inc., Chief Financial Officer & SVP-Business Development at Transplantation Technologies, Inc., SVP-Strategy & Business Development at AB Sciex LLC in 2010, and Chief Innovation Officer at Syneos Health Clinique, Inc. Education includes an MBA from McGill University and an undergraduate degree from the University of British Columbia.